CKPT - チェックポイント・セラピュ―ティクス (Checkpoint Therapeutics Inc.) チェックポイント・セラピュ―ティクス

 CKPTのチャート


 CKPTの企業情報

symbol CKPT
会社名 Checkpoint Therapeutics Inc (チェックポイント・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Checkpoint Therapeutics Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition development and commercialization of non-chemotherapy immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1) glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral small molecules targeted anti-cancer agents consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations an inhibitor of the bromodomain and extra-terminal (BET) protein BRD4 and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.   チェックポイント・セラピュ―ティクスは米国のバイオ医薬品企業。主にがん腫瘍を治療するための非化学療法や免疫療法の開発・商業化に従事する。認可された同社の抗体ポ―トフォリオには、グルココルチコイド誘発TNFR関連タンパク質および炭酸脱水酵素を標的とする抗体が含まれる。また、経口抗がん療法も開発する。本社所在地はニューヨーク。   Checkpoint Therapeutics, Inc. ('Checkpoint') is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Checkpoint is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-PD-L1 antibody licensed from the Dana-Farber Cancer Institute, in an ongoing global, open-label, multicohort Phase 1 clinical trial in checkpoint therapy-naïve patients with selected recurrent or metastatic cancers, including ongoing cohorts in locally advanced and metastatic cutaneous squamous cell carcinoma intended to support one or more applications for marketing approval. In addition, Checkpoint is evaluating its lead small-molecule, targeted anti-cancer agent, CK-101, a third-generation epidermal growth factor receptor ('EGFR') inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer. Checkpoint is headquartered in New York City and was founded by Fortress Biotech, Inc.
本社所在地 2 Gansevoort Street 9th Floor New York NY 10014 USA
代表者氏名
代表者役職名
電話番号 +1 212-554-4366
設立年月日 41944
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数
url www.checkpointtx.com
nasdaq_url https://www.nasdaq.com/symbol/ckpt
adr_tso
EBITDA EBITDA(百万ドル) -27.35000
終値(lastsale) 3.32
時価総額(marketcap) 106598108.48
時価総額 時価総額(百万ドル) 89.25986
売上高 売上高(百万ドル) 1.15100
企業価値(EV) 企業価値(EV)(百万ドル) 60.95586
当期純利益 当期純利益(百万ドル) -27.25000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Checkpoint Therapeutics Inc revenues decreased 55% to $470K. Net loss increased 42% to $15.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development - Balancin increase of 76% to $12.1M (expense) General and administrative - Balanci increase of 53% to $2.6M (expense).

 CKPTのテクニカル分析


 CKPTのニュース

   Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences  2021/09/09 12:30:00 Intrado Digital Media
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (Checkpoint) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in two upcoming investor conferences. Details are as follows:
   Opaleye Management Inc. Buys Kiniksa Pharmaceuticals, Larimar Therapeutics Inc, CM Life ...  2021/08/24 02:38:05 GuruFocus
Related Stocks: KNSA , KROS , STRO , OPTN , TELA , LPTX , LRMR , CMLF , FMTX , VIRX , PHVS , CDTX , AUTL , GMTX , CKPT , IMVT , CBIO , FGEN ,
   Pvg Asset Management Corp Buys PowerShares QQQ Trust Ser 1, ProShares UltraShort S&P500, ...  2021/08/19 15:38:08 GuruFocus
Related Stocks: SDS , HEPA , CLRB , CKPT , QLIS , QQQ , XSD , GOED , UFO , OIH , EWW , SPY , RWM , IWD , IYC , XLB , T ,
   Traders should divert their intention on this Stock: Senseonics Holdings, Inc. (AMEX:SENS), Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)  2021/08/16 00:28:32 Stock Equity
Senseonics Holdings, Inc. (SENS) with the stream of -8.73% also noticed, India Checkpoint Therapeutics, Inc. (CKPT) encountered a rapid change of -2.85% in the last hour of trading session. Senseonics The post Traders should divert their intention on this Stock: Senseonics Holdings, Inc. (AMEX:SENS), Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) appeared first on Stocks Equity .
   Checkpoint Therapeutics EPS misses by $0.02, beats on revenue  2021/08/05 21:26:29 Seeking Alpha
   Stock Buzzers: Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Ra Medical Systems, Inc. (AMEX:RMED)  2021/06/14 23:01:23 Stock Equity
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) with the stream of -1.83% also noticed, India Ra Medical Systems, Inc. (AMEX:RMED) encountered a rapid change of -3.19% in the last hour of Mondays trading The post Stock Buzzers: Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Ra Medical Systems, Inc. (AMEX:RMED) appeared first on Stocks Equity .
   Momentum Technology Stock- Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) encountered the change of -4.70%  2021/06/10 21:38:35 Stock Equity
On Thursday, Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) reached at $3.02 price level during last trade its distance from 20 days simple moving average was 16.64%, and its distance from The post Momentum Technology Stock- Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) encountered the change of -4.70% appeared first on Stocks Equity .
   Why Checkpoint Therapeutics Skyrocketed Today  2021/06/09 22:01:24 The Motley Fool
One analyst becomes a fervent believer in the company''s stock.
   Glowing Stocks Review: Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Washington Prime Group Inc. (NYSE:WPG)  2021/06/09 20:59:13 Stock Equity
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) with the stream of 28.38% also noticed, India Washington Prime Group Inc. (NYSE:WPG) encountered a rapid change of 10.80% in the last hour of trading session. The post Glowing Stocks Review: Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Washington Prime Group Inc. (NYSE:WPG) appeared first on Stocks Equity .
   5 Top Stock Gainers for Wednesday: SPI Energy, Checkpoint Therapeutics  2021/06/09 16:02:51 The Street
SPI Energy, Checkpoint Therapeutics, Aethlon Medical, Clovis Oncology and World Wrestling Entertainment are five top gainers for Wednesday.
   Momentum Technology Stock- Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) encountered the change of -4.70%  2021/06/10 21:38:35 Stock Equity
On Thursday, Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) reached at $3.02 price level during last trade its distance from 20 days simple moving average was 16.64%, and its distance from The post Momentum Technology Stock- Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) encountered the change of -4.70% appeared first on Stocks Equity .
   Why Checkpoint Therapeutics Skyrocketed Today  2021/06/09 22:01:24 The Motley Fool
One analyst becomes a fervent believer in the company''s stock.
   Glowing Stocks Review: Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Washington Prime Group Inc. (NYSE:WPG)  2021/06/09 20:59:13 Stock Equity
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) with the stream of 28.38% also noticed, India Washington Prime Group Inc. (NYSE:WPG) encountered a rapid change of 10.80% in the last hour of trading session. The post Glowing Stocks Review: Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Washington Prime Group Inc. (NYSE:WPG) appeared first on Stocks Equity .
   5 Top Stock Gainers for Wednesday: SPI Energy, Checkpoint Therapeutics  2021/06/09 16:02:51 The Street
SPI Energy, Checkpoint Therapeutics, Aethlon Medical, Clovis Oncology and World Wrestling Entertainment are five top gainers for Wednesday.
   Aethlon Medical, Checkpoint Therapeutics leads healthcare gainers; Atossa Therapeutics, CEL-SCI among major losers  2021/06/09 15:07:04 Seeking Alpha

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 チェックポイント・セラピュ―ティクス CKPT Checkpoint Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)